Strategies for NSCLC: Clinical Pathways in the Era of Biomarker-Driven Care

Strategies for NSCLC: Clinical Pathways in the Era of Biomarker-Driven Care

HMP CME

2 months
13 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Earn CME: https://www.naccme.com/program/19-cpc-101-3 This webcast features a presentation by Dr. David Jackman discusses the latest efficacy and safety data, indications, and cost utility of novel therapies into optimal selection and non-small cell lung cancer (NSCLC) pathway placement strategies. © 2019 NACCME, an HMP Company

Up Next Autoplay